Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 37Central Nervous System Neoplasms 23Colorectal Neoplasms 20Glioblastoma 18Gliosarcoma 17Colonic Neoplasms 16Rectal Neoplasms 15Head and Neck Neoplasms 12Sarcoma 10Ovarian Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Esophageal Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Brain Neoplasms 9Stomach Neoplasms 8Prostatic Neoplasms 8Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Breast Carcinoma In Situ 7Astrocytoma 7Adenocarcinoma Of Esophagus 7Salivary Gland Neoplasms 6Glioma 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Neoplasm Metastasis 5Fallopian Tube Neoplasms 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5

Interventions

Cisplatin 15Gemcitabine 7Fluorouracil 6Docetaxel 6Radiotherapy, Intensity-Modulated 5Oxaliplatin 4Capecitabine 4pembrolizumab 3Radiotherapy 3Carboplatin 3Acupuncture Therapy 3Psychiatric Rehabilitation 2Paclitaxel 2Nicotine 2Counseling 2Cetuximab 2Celecoxib 2Bupropion 2tislelizumab 1spartalizumab 1sargramostim 1motexafin gadolinium 1fosaprepitant 1fialuridine 1endostar protein 1cc-486 1apatinib 1Zoledronic Acid 1Zinc Oxide 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Nasopharyngeal Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00370890 2022-02-17

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Chinese University of Hong Kong

Phase 3 Completed
104 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡